HRT Financial’s United Therapeutics UTHR Stock Holding History

HRT Financial’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$56.2M	Sell	103,700 -115,000	-53%	-$64.8M	0.1%	169
2026 Q1	$130M	Buy	+218,700	New	+$109M	0.32%	42

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Norges Bank Oslo, Norway $1T AUM

HRT Financial's UTHR Position: Q2 2026 in Review

HRT Financial increased its United Therapeutics (UTHR) stake by 48% in Q2 2026, buying an estimated $18M and bringing the position to 98,864 shares worth $53.6M. The position accounts for 0.1% of the portfolio, ranked #183.

HRT Financial first reported a position in UTHR in Q2 2019 and has held it in 20 quarters since. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

HRT Financial held 98,864 shares of United Therapeutics worth $53.6M as of Q2 2026.
HRT Financial bought 32,022 United Therapeutics shares in Q2 2026, an estimated $18M.
United Therapeutics made up 0.1% of HRT Financial's portfolio in Q2 2026, its #183 holding.
HRT Financial first reported a position in United Therapeutics in Q2 2019 and has held it in 20 quarters since.
880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.